Evidence map›Paper›PMID 37644350›Full record

ArticleThe journal of behavioral health services & research2024

A Cost Model for a Low-Threshold Clinic Treating Opioid Use Disorder.

Sarah E Wakeman, Elizabeth Powell, Syed Shehab, Grace Herman, Laura Kehoe, Robert S Kaplan

Abstract read
PubMed Publisher
In one paragraph

Article in The journal of behavioral health services & research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

Sarah E WakemanDepartment of Medicine, Massachusetts General Hospital, Boston, USA.
Elizabeth PowellDepartment of Psychiatry, Massachusetts General Hospital, Boston, USA.
Syed ShehabHarvard University, Cambridge, USA.
Grace HermanJacobs School of Medicine at University of Buffalo, Buffalo, USA.
Laura KehoeDepartment of Medicine, Massachusetts General Hospital, Boston, USA.
Robert S KaplanHarvard University, Cambridge, USA. rkaplan@hbs.edu.ORCID 0000-0001-7429-5583
Harvard University · USBoston University · USHarvard University Press · USJacobs (United States) · USMassachusetts General Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The US fee-for-service payment system under-reimburses clinics offering access to comprehensive treatments for opioid use disorder (OUD). The funding shortfall limits a clinic's ability to expand and improve access, especially for socially marginalized patients with OUD. New payment models, however, should reflect the high variation in cost for using a clinic's clinical and voluntary psychosocial and recovery support services. The authors applied time-driven activity-based costing, a patient-level, micro-costing approach, to estimate the cost at an outpatient clinic that delivers medication for opiate used disorder (MOUD) and voluntary psychosocial and recovery support services. Much of the cost variation could be explained by classifying patients into three archetypes: (1) light touch (1-3 visits): no significant co-occurring psychiatric illness, stable housing, and easy to connect for ongoing OUD treatment in a traditional outpatient setting; (2) standard (average of 8 visits): initially requires an integrated team-based care model but soon stabilizes for transition to community-based outpatient care; (3) quad morbidity (> 20 visits): multiple co-occurring substance use disorders, unhoused, co-occurring medical and psychiatric complexity, and limited social supports. With the cost of the initial visit set at an indexed value of 100, an average light touch patient had a cost of 352, a standard patient was 718, and a quad morbidity patient was 1701. The cost structure revealed by this analysis provides the foundation for alternative payment models that would enable new MOUD clinics, staffed with multi-disciplinary care teams, and located for convenient access by high-risk patients, to be established and sustained.

Indexed as

BuprenorphineOpioid-Related DisordersAmbulatory CareAmbulatory Care FacilitiesAnalgesics, OpioidHumansOpiate Substitution TreatmentOutpatientsSocial SupportAnalgesics, OpioidBuprenorphine

Identifiers

PMID37644350
OpenAlexW4386257179

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.